Trial Information
DAHANCA 24: Prognostic Value of 18F-FAZA Positron Emission Tomography After Primary Curative Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
Inclusion Criteria:
- Histological proven squamous cell carcinoma of the pharynx, larynx, oropharynx and
hypopharynx
- Curative intent and no prior treatment
- Age >= 18 years
- stage T1-4 N0-N3 M0.
- Informed consent according to local guidelines and national law
- The patient is able (psychological, sociological, geographical and physical) to carry
through the treatment and follow-up
- Fertile women must use contraceptive devices (IUD or oral contraceptives)
Exclusion Criteria:
- No serious concurrent medical disease
- No metastasis
- No prior disease that can affect the treatment, evaluation or outcome of current
disease
- No pregnant or breastfeeding woman
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Can 18F-FAZA can be used as a prognostic marker in HNSCC?
Outcome Time Frame:
1, 5 years
Safety Issue:
No
Principal Investigator
Jens Overgaard, Prof., MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Danish Head and Neck Cancer Group (DAHANCA)
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
DAHANCA 24
NCT ID:
NCT01017224
Start Date:
November 2009
Completion Date:
May 2012
Related Keywords:
- Cancer of the Head and Neck
- Carcinoma
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms